Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi presents preliminary data from a first-in-human study of SAR-439859

June 12, 2019

Topline 12-week data reported from an ongoing phase IIb study of seladelpar in NASH

June 12, 2019

Pharming initiates phase I/II study of Ruconest in patients with pre-eclampsia

June 12, 2019

FDA clears IND for Sleeping Beauty TCR-T-cell therapy trial

June 12, 2019

FDA approves Keytruda for two new indications

June 12, 2019

Eli Lilly initiates phase I study of its bispecific antibody LY-3434172

June 12, 2019

VTS-270 does not show efficacy in phase II/III study in type C Niemann-Pick disease

June 12, 2019

Phase II data presented for NS-0200 in obesity

June 12, 2019

Deciphera adds first-in-class autophagy inhibitor to pipeline

June 12, 2019

Clinical data show potential for improved renal transplant outcomes with CFZ-533

June 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...